<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01757444</url>
  </required_header>
  <id_info>
    <org_study_id>2012 - A00731 - 42</org_study_id>
    <secondary_id>EVAL CLIN - VENTILATEUR</secondary_id>
    <nct_id>NCT01757444</nct_id>
  </id_info>
  <brief_title>Non Invasive Ventilation : Efficacy of a New Ventilatory Mode in Patients With OHS</brief_title>
  <official_title>Clinical Benefits and Tolerance to a New Ventilatory Mode in Patients With Obesity Hypoventilation Syndrome (OHS).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 2012, it has announced the availability of the new ventilator (BiPAP- A40), which could
      offer potential advantages over fixed level pressure support, in particular, in patients with
      obesity hypoventilation syndrome (OHS). One of the key benefits of the BiPAP A40 is an
      innovative ventilation mode called AVAPS-AE, which automatically maintains airway patency
      while delivering the correct level of ventilation each user requires, whatever their body
      position or sleep stage. AVAPS-AE mode is also aimed to help the clinicians during the
      initial titration of therapy, while providing long term comfort and assuring therapy
      compliance. However, studies on the physiologic and clinical effects have not yet been
      performed. The aim of our singled-blind randomised multicentre controlled trial is to
      prospectively investigate the effects of BiPAP with the spontaneous/timed (S/T) or the
      AVAPS-AE ventilation mode over 8 weeks on sleep quality, ventilation pattern, gas exchange,
      symptoms, body composition, level of physical activity and health-related quality of life in
      OHS patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Efficacy on sleep quality, symptoms, physical activity and quality of life
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CHANGE IN SLEEP QUALITY</measure>
    <time_frame>Day 1 and Day 61</time_frame>
    <description>Sleep stage, micro arousals, apnea/hypopnea index...</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CHANGE IN GAZ EXCHANGE</measure>
    <time_frame>Day 1 and Day 61</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>CHANGE IN QUALITY OF LIFE/ LEVEL OF PHYSICAL ACTIVITY/ BODY COMPOSITION</measure>
    <time_frame>Day 1 and Day 61</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Obesity Hypoventilation Syndrome</condition>
  <arm_group>
    <arm_group_label>BiPAP - A40</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BiPAP with AVAPS AE mode</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BiPAP- ST</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving BiPAP- ST at home</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiPAP - A40</intervention_name>
    <description>Patients receiving BiPAP AVAPS - AE ventilatory mode at home</description>
    <arm_group_label>BiPAP - A40</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiPAP - ST</intervention_name>
    <description>Patients receiving BiPAP- ST mode at home.</description>
    <arm_group_label>BiPAP- ST</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman, stable patient with obesity hypoventilation syndrome, naives of non
             invasive ventilation.

          -  PaCO2 ≥ 45 mmHg.

          -  PaO2 &lt; 70 mmHg

          -  BMI ≥ 30Kg. m2

        Exclusion Criteria:

          -  Chronic obstructive pulmonary disease

          -  Neuromuscular disease

          -  Scoliosis

          -  Cardiac insufficiency

          -  Significant psychiatric disease

          -  Sleep apnea syndrome with central apnea index &gt; 10%

          -  Treatment with benzodiazepines at the inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-François MUIR, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacqueline DELRIEU, Ph.D</last_name>
    <email>delrieu@antadir.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric GAGNADOUX, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Béziers</name>
      <address>
        <city>Beziers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic GOUTORBE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Haut- Lévêque</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Cannes</name>
      <address>
        <city>Cannes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe PERRIN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique du Parc</name>
      <address>
        <city>Castelnau-le-Lez</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe BROUSSE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital du Bocage</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio RABEC, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Michallon</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Louis PEPIN, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas SIMILOWSKI, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital La Milétrie</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Claude MEURICE, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de Bois Guillaume</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean François MUIR, Pr</last_name>
      <email>Jean-Francois.Muir@chu-rouen.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Larrey</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2012</study_first_submitted>
  <study_first_submitted_qc>December 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2012</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche</investigator_affiliation>
    <investigator_full_name>DELRIEU Jacqueline</investigator_full_name>
    <investigator_title>Coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

